Home/Filings/4/0001209191-21-008278

4//SEC Filing

Wicklow Capital Inc. 4

Accession 0001209191-21-008278

CIK 0001776932other

View on SEC.gov Company Profile

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 6:23 PM ET

Size

15.3 KB

Accession

0001209191-21-008278

Insider Transaction Report

Form 4

Period: 2021-02-03

MedMen Enterprises, Inc.MMNFF

Wicklow Capital Inc.

10% Owner

Transactions

Sale
Class B Subordinate Voting Shares
2021-02-03$0.22/sh−714,629$156,361→ 16,531,036 total(indirect: By Milestone. See footnote 4.)
Sale
Class B Subordinate Voting Shares
2021-02-04$0.29/sh−234,651$68,448→ 16,299,385 total(indirect: By Milestone. See footnote 4.)

Holdings

Class B Subordinate Voting Shares
(indirect: By Clarence, LP. See footnote 4.)
6,395,433
Class B Subordinate Voting Shares
(indirect: By Clarence, LP. See footnote 4.)
22,353,472
Class B Subordinate Voting Shares
(indirect: By Milestone. See footnote 4.)
12,195,122

DAN TIERNEY & DANIEL V. TIERNEY 2003 TRUST

10% Owner

Transactions

Sale
Class B Subordinate Voting Shares
2021-02-03$0.22/sh−714,629$156,361→ 16,531,036 total(indirect: By Milestone. See footnote 4.)
Sale
Class B Subordinate Voting Shares
2021-02-04$0.29/sh−234,651$68,448→ 16,299,385 total(indirect: By Milestone. See footnote 4.)

Holdings

Class B Subordinate Voting Shares
(indirect: By Clarence, LP. See footnote 4.)
22,353,472
Class B Subordinate Voting Shares
(indirect: By Clarence, LP. See footnote 4.)
6,395,433
Class B Subordinate Voting Shares
(indirect: By Milestone. See footnote 4.)
12,195,122

Tierney Daniel

10% Owner

Transactions

Sale
Class B Subordinate Voting Shares
2021-02-03$0.22/sh−714,629$156,361→ 16,531,036 total(indirect: By Milestone. See footnote 4.)
Sale
Class B Subordinate Voting Shares
2021-02-04$0.29/sh−234,651$68,448→ 16,299,385 total(indirect: By Milestone. See footnote 4.)

Holdings

Class B Subordinate Voting Shares
(indirect: By Clarence, LP. See footnote 4.)
22,353,472
Class B Subordinate Voting Shares
(indirect: By Clarence, LP. See footnote 4.)
6,395,433
Class B Subordinate Voting Shares
(indirect: By Milestone. See footnote 4.)
12,195,122

Milestone Investments, LP

10% Owner

Transactions

Sale
Class B Subordinate Voting Shares
2021-02-03$0.22/sh−714,629$156,361→ 16,531,036 total(indirect: By Milestone. See footnote 4.)
Sale
Class B Subordinate Voting Shares
2021-02-04$0.29/sh−234,651$68,448→ 16,299,385 total(indirect: By Milestone. See footnote 4.)

Holdings

Class B Subordinate Voting Shares
(indirect: By Clarence, LP. See footnote 4.)
22,353,472
Class B Subordinate Voting Shares
(indirect: By Clarence, LP. See footnote 4.)
6,395,433
Class B Subordinate Voting Shares
(indirect: By Milestone. See footnote 4.)
12,195,122

Footnotes (6)

[F1]This Form 4 is being filed jointly by Wicklow Capital, Inc., an Illinois corporation ("Wicklow"), Milestone Investments, LP, an Alaska limited partnership ("Milestone"), the Dan Tierney & Daniel V. Tierney 2003 Trust (the "Trust"), and Daniel V. Tierney (collectively, the "Reporting Persons").
[F2]The aggregate number of Class B Subordinate Voting Shares ("Class B Shares") of Issuer sold on the same day at different prices, which are reported herein in Canadian dollars ("CAN$").
[F3]Represents the weighted average sales price. The Class B Shares were sold at prices ranging from CAN$0.213 to CAN$0.225 per share. Full information regarding the number of such shares sold at each price shall be provided to the Securities and Exchange Commission staff (the "Staff"), Issuer or any security holder, upon request.
[F4]Wicklow is the general partner of each of Milestone and Clarence, LP ("Clarence"). The Trust is the sole stockholder of Wicklow and the sole limited partner of Milestone and Clarence. Daniel V. Tierney is the trustee and sole beneficiary of the Trust and has voting and/or dispositive power over the securities of Issuer held by Wicklow, Milestone and Clarence. As a result, Daniel V. Tierney and the Trust may be deemed to indirectly beneficially own the securities of Issuer held by Wicklow, Milestone and Clarence. Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest, if any, therein.
[F5]See footnote 1.
[F6]Represents the weighted average sales price. The Class B Shares were sold at prices ranging from CAN$0.29 to CAN$0.295 per share. Full information regarding the number of such shares sold at each price shall be provided to the Staff, Issuer or any security holder, upon request.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

MedMen Enterprises, Inc.

CIK 0001776932

→

Entity typeother

IncorporatedIL

Related Parties

filerCIK 0001602355

Filing Metadata

Form type: 4
Filed: Feb 4, 7:00 PM ET
Accepted: Feb 5, 6:23 PM ET
Size: 15.3 KB

View on SEC.gov